Related Experiment Video

Updated: Jun 27, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Treatment strategies in atrial fibrillation

K C K Wong1, T R Betts

  • 1Cardiac Rhythm Management, Cardiology Department, John Radcliffe Hospital, Headington, Oxford, UK.

Minerva Cardioangiologica
|December 19, 2008
PubMed

Insights

Atrial fibrillation (AF), a common heart rhythm disorder, affects 1% of people, increasing with age and heart disease. This review explores current and emerging treatments for managing AF effectively.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Practice

Background:

  • Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, impacting up to 1% of the general population.
  • Prevalence and incidence of AF increase with age and the presence of chronic heart disease.
  • Managing AF poses challenges due to its complexity and the availability of diverse therapeutic strategies.

Purpose of the Study:

  • To review the wide range of therapeutic options for atrial fibrillation (AF).
  • To discuss the optimal application of both pharmacological and non-pharmacological treatments for AF.
  • To provide insights into the management of this common cardiac arrhythmia.

Main Methods:

  • Literature review of current and emerging treatments for atrial fibrillation.
  • Analysis of pharmacological and non-pharmacological therapeutic approaches.
  • Discussion of treatment strategies based on clinical evidence and guidelines.

Main Results:

  • A comprehensive overview of available AF treatments is presented.
  • Guidance on selecting and applying therapies for effective AF management is discussed.
  • The review highlights the evolving landscape of AF treatment options.

Conclusions:

  • Effective management of atrial fibrillation requires a thorough understanding of available therapeutic options.
  • Tailoring treatment strategies to individual patient needs is crucial for optimal outcomes in AF.
  • Continued research and clinical evaluation are essential for advancing AF care.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.